Steiner, Günter

Osteoclasts are essential for TNF-α-mediated joint destruction.

Redlich, K., Hayer, S., Ricci, R., David, J.-P., Tohidast-Akrad, M., Kollias, G., Steiner, G., Smolen, J. S., Wagner, E. F., & Schett, G. (2002) · Journal of Clinical Investigation

Rheumatoid Arthritis Research and TherapiesBone Metabolism and Diseases

Cited by 474

Tumor necrosis factor α-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin.

Redlich, K., Hayer, S., Maier, A., Dunstan, C. R., Tohidast‐Akrad, M., Lang, S., Türk, B., Pietschmann, P., Woloszczuk, W., Haralambous, S., et al. (2002) · Arthritis & Rheumatism

Rheumatoid Arthritis Research and TherapiesBone Metabolism and Diseases

Cited by 285

Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice.

Schett, G., Redlich, K., Hayer, S., Zwerina, J., Bolon, B., Dunstan, C., Görtz, B., Schulz, A., Bergmeister, H., Kollias, G., et al. (2003) · Arthritis & Rheumatism

Bone Metabolism and DiseasesRheumatoid Arthritis Research and Therapies

Cited by 150

Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritis.

Redlich, K., Görtz, B., Hayer, S., Zwerina, J., Doerr, N., Kostenuik, P., Bergmeister, H., Kollias, G., Steiner, G., Smolen, J. S., et al. (2004) · The American Journal of Pathology

Rheumatoid Arthritis Research and TherapiesBone Metabolism and Diseases

Cited by 134

Development of a new occupational balance-questionnaire: incorporating the perspectives of patients and healthy people in the design of a self-reported occupational balance outcome instrument

Dür, M., Steiner, G., Fialka-Moser, V., Kautzky-Willer, A., Dejaco, C., Prodinger, B., Stoffer, M. A., Binder, A., Smolen, J., & Stamm, T. A. (2014) · Health and Quality of Life Outcomes

Occupational Therapy Practice and ResearchPsychometric Methodologies and Testing

Cited by 59

Histone deacetylases 1 and 2 restrain CD4+ cytotoxic T lymphocyte differentiation

Preglej, T., Hamminger, P., Luu, M., Bulat, T., Andersen, L., Göschl, L., Stolz, V., Rica, R., Sandner, L., Waltenberger, D., et al. (2020) · JCI Insight

T-cell and B-cell ImmunologyHistone Deacetylase Inhibitors Research

Cited by 36